Becton Dickinsonvs.GE HealthCare
BDX vs GEHC · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Becton Dickinson is about 1.4× larger than GE HealthCare by market cap; GE HealthCare trades at the lower P/E (15.4 vs 36.8); year to date, Becton Dickinson leads (−0.4% vs −21.1%).
Side by side
| BDX | GEHC | |
|---|---|---|
| Market cap | $41.9B | $29.4B |
| Price | $151.94 | $64.70 |
| Today | +0.7% | +0.0% |
| Return YTD | −0.4% | −21.1% |
| Return 1Y | +8.9% | −15.4% |
| P/E | 36.8 | 15.4 |
| P/S | 2.0 | 1.4 |
| P/B | 1.7 | 2.8 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Becton DickinsonBDX
American medtech group with a broad portfolio of medical consumables, diagnostics and drug delivery (syringes, needles).
Full BDX profile →GE HealthCareGEHC
Medical imaging (CT, MRI, ultrasound) and patient monitoring globally.
Full GEHC profile →More comparisons in Medtech & devices
See where BDX and GEHC sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →